These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3497285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS, Kim CM, Lee JO, Kang TW, Yun TK, Kim CY.
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [Abstract] [Full Text] [Related]

  • 7. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
    Watanabe Y, Hashizume Y, Shimizu J, Yoshida M, Watanabe S, Iwa T, Sakai S, Migita S, Sato H, Murayama T.
    Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
    [Abstract] [Full Text] [Related]

  • 8. [Strategy of cancer treatment using human recombinant interleukin 2 and lymphokine activated killer cells].
    Saijo N, Ozaki A, Ishihara J, Sakurai M, Sasaki Y, Takahashi H, Sano T, Hoshi A.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1290-7. PubMed ID: 3488026
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T.
    Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
    [Abstract] [Full Text] [Related]

  • 14. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
    Tatake RJ, Krishnan N, Rao RS, Fakih AR, Gangal SG.
    Int J Cancer; 1989 Apr 15; 43(4):560-6. PubMed ID: 2522911
    [Abstract] [Full Text] [Related]

  • 15. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
    Xu ZY.
    Zhonghua Zhong Liu Za Zhi; 1990 Sep 15; 12(5):345-7. PubMed ID: 2177396
    [Abstract] [Full Text] [Related]

  • 16. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 15; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 17. [Treatment with autologous tumor-infiltrating lymphocytes and recombinant interleukin-2 in patients with lung carcinoma].
    Li D, Zhang X, Song Y.
    Zhonghua Zhong Liu Za Zhi; 1995 Mar 15; 17(2):152-5. PubMed ID: 7656811
    [Abstract] [Full Text] [Related]

  • 18. In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.
    McMannis JD, Fisher RI, Creekmore SP, Braun DP, Harris JE, Ellis TM.
    J Immunol; 1988 Feb 15; 140(4):1335-40. PubMed ID: 3257776
    [Abstract] [Full Text] [Related]

  • 19. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):67-75. PubMed ID: 2989604
    [Abstract] [Full Text] [Related]

  • 20. [The characteristic of lymphokine-activated killer cells induced from tumor draining lymph-node cell].
    Meng YG, Fu CY, Wang YZ.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep 15; 29(9):535-7, 574. PubMed ID: 7835130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.